Healthcare
ICG's DomusVi to bolt on Residalya
Under the ICG ownership, DomusVi also acquired the Spain-based Sarrikue Group in 2018
XAnge leads €2.5m round for Synapse Medicine
Startup plans to use the funding to scale up its team, optimise its database and boost its expansion
Eurazeo to invest €300m in DORC
GP enters exclusive discussions with Montagu PE to buy vitreoretinal surgery specialist
LSP in $50m series-A for Snipr Biome
Lundbeckfonden Emerge invested an undisclosed sum in an exploratory investment in 2017
Summa buys Olink Proteomics
Management team led by Ulf Landgren will remain as minority shareholders after the deal
RDCP gears up to launch second fund
RDCP Healthcare Opportunities Fund II will target £50m, to deploy in healthcare assets
Penta-backed Sensiblu buys Belladonna
Belladonna had 93 pharmacies prior to the trasnaction and the divested subsidiary includes 46
Permira-backed Corin boosts US presence with Omni bolt-on
Omni, which makes robotics-assisted medial equipment, is Corin's second bolt-on under Permira
Gilde Healthcare closes third fund on €200m
Gilde Healthcare Services III targets healthcare providers based in the Benelux and DACH regions
Towerbrook's ICS secures refinancing package
Transaction comes almost five years after the GP acquired the business in an SBO from Blackstone
Seventure holds first close for Health for Life II
Investments can range from between €500,000-10m per round, or up to €20m per company
Pureos Bioventures leads CHF 10m series-A for NovaGo
Swiss clinical-stage biotech company Neurimmune also takes part in the investment
Segulah sells CCS to trade
Segulah supported several bolt-on acquisitions and also made partial divestments
Redmile Group invests in Hookipa's €33.2m series-D
Hookipa's previous investors include Sofinnova Partners, Takeda Ventures and Forbion
Syncona leads CHF 35m series-A for Anaveon
Anaveon initially received seed funding from the UZH Life Sciences Fund and BaseLaunch
IK’s Colisée bolts on Armonea Group
Combined group could generate revenues of €1bn and host 26,800 residents
Palamon announces roll-over investment into Ober Scharrer
GP sold Ober Scharrer to Nordic last year, generating a 3.6x return on its original investment
Innova Capital sells Neomedic in €70.5m deal
Sale of obstetrics-focused hospital group brings to an end a seven-year holding period
Ardian sells Citoxlab to trade in €448m deal
Sale price implies a 13.8x pro forma EBITDA multiple, based on Citoxlab’s latest results
HTGF in seed round for 8sense
Beurer Group invested in 2018 and HGTF was joined by Thieme Group and a business angel in the round
US healthcare funds buy Moberg Pharma's OTC business for $155m
Purchase price represents a 14.1x entry multiple for the investors and is 3.3x the group’s revenues
Sunstone holds €80m first close for fourth life science fund
Sunstone Life Science Ventures Fund IV expects to close on its €150m target by early 2020
CBPE acquires Simbec-Orion
GP acquires the life sciences research firm from Wales Life Sciences Investment Fund
Graphite sells Sk:n to TriSpan after 13-year holding
Deal reportedly values the UK-headquartered skincare clinic operator at around £35m
